Human isotope fractional absorption studies comparing chelated Magnesium Glycinate vs. Citrate vs. 4% Oxide, CYP2R1/CYP27B1 magnesium-dependent Vitamin D3 activation trials, and Metformin-induced Vitamin B12 holotranscobalamin depletion. Explore 4,327 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
T2DM represents a risk factor for the insurgence of pNET and is a significant predictor of poor post-treatment TFS of pNET patients.
From the perspective of the Chinese healthcare system, nivolumab was not as cost-effective as placebo for relapsed malignant mesothelioma.
Both finasteride and hydroxychloroquine are equally effective, safe, and well-tolerable for treating FFA patients.
PCV20 generated robust immune responses to all vaccine serotypes in older adults in Japan, South Korea, and Taiwan.
In patients with worse clinical outcomes at month 3, mean nocturnal oxygen saturation was lower whereas there was no association with apnea-hypopnea index.
In our trial, LLLT was demonstrated as a useful supplementary treatment for FPHL and the combination with 2 % minoxidil accomplished better improvement in intermediate hair enlargement and hair diameter of midscalp for FPHL.
This is the largest RCT evaluating PF creation for LC prevention and met its primary endpoint, the reduction of SLCs.
Safinamide was shown to improve PD symptoms and quality of life in different ethnic populations, without any treatment by race interaction.
The ERASur trial employs a pragmatic interventional design to test the real-world benefits and safety of adding multimodality TAT to standard of care systemic therapy in patients with limited mCRC.
Significantly more patients receiving dupilumab vs placebo achieved the composite endpoint in both the FAS (77.7% vs 24.6%, p < 0.0001) and subgroup (68.9% vs 21.5%, p < 0.0001).
The benefit of edoxaban 15 mg was consistent in older adults patients with irregular heartbeat (AFib) and extremely low body weight, though clinicians must remain vigilant about the risk of major bleeding, especially...
Both treatment arms showed similar efficacy among selected populations with high-risk features.
Based on our results, synbiotic had beneficial effects on some pregnancy outcomes.
OSA is associated with DM and preDM.
The Clavien-Dindo classification of adverse event grades revealed no significant differences between HIPEC and controls ( p = 0.482).
In middle-aged and older men with hypogonadism and low libido, TRT for 2 years improved sexual activity, hypogonadal symptoms, and sexual desire, but not erectile function.
HBV-miR-3 is new biomarker for HBV replication and positively correlated to HBV replication.
In vitro and clinical evaluation results indicate that SNaP is highly effective in coating the dentin surface, occluding exposed dentin tubules, and offering sensitivity relief from the first day of use, a benefit that...
Lavender effectively increased progesterone levels and regulated the menstrual cycles in PCOS patients, similar to metformin.
This study offers reassurance that TRT does not increase mortality risk or worsen heart and blood vessel outcomes in hypogonadal men.
PRP therapy can be a useful alternative to applied to the skin minoxidil in the treatment of AGA.
Presence of ADA (with or without NAb) was associated with lower drug concentrations and faster clearance but not with the development of immunologically related AEs.
This early health technology assessment model used inclusion criteria from clinical trials.
After six years, 44.1% of the cyclophosphamide group scored an SF-36 PF of at least 70, and 17.6% of at least 90, suggesting that cyclophosphamide in a subgroup may modulate the disease course in a beneficial way.
However, they experienced worsening of diarrhea and/or nausea/vomiting.
The most common AEs in the fostamatinib group were diarrhea (26.7%), high blood pressure (24.4%), and fatigue (15.6%).
Patients initially planned for WP radiation with field decision change to PB-only radiation after PET showed (1) no significant difference in 3-year bRFS compared with patients initially planned for PB-only radiation; and (2)...
These results indicate a strong association between WMH and MCH, a common manifestation of cerebral amyloid angiopathy and ARIA-H.
Group A's LDL-c reduction effect and target achievement proportion (Rosuvastatin 10mg + Ezetimibe 10 mg) were significantly higher than Group B's (Rosuvastatin 20 mg).
Real-world benefits and safety data support abrocitinib use to manage AD in patients with or without allergic comorbidities.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
